SIU Central Office
1155 University, Suite 1155
Montreal, QC
Canada H3B 3A7
T +1 514 875-5665
F +1 514 875-0205
congress@siucongress.org
1155 University, Suite 1155
Montreal, QC
Canada H3B 3A7
T +1 514 875-5665
F +1 514 875-0205
congress@siucongress.org
Scientific Programme
Click here to see Final Programme
Wednesday , october 13
0900-1300PAUSA Symposium
Welcome from PAUSA President
Welcome from SIU Scientific Chairs
Session 1
Chairs: Fethi Meziane, Morocco
Saeed Samnakay, Kenya
Société Marocaine d’Urologie: Abdennabi Joual, Morocco Nigerian Association of Urological Surgeons: Leslie Akporiaye, Alexander Nwofor, Nigeria Société Tunisienne d’Urologie: Use of Irrigation Fluid in Urology: Which Fluid and Why? Yassine Nouira, Tunisia Association Ivoirienne d’Urologie: Georges Armand Ouegnin, Ivory Coast UroLink Lecture: Establishing and Maintaining an Overseas Link - Lessons To Be Learnt: George Fowlis, UKBreak
Session 2
Chair: Yassine Nouira, Tunisia,
Egyptian Association of Urology: Mohamed Eissa, Egypt Association Sénégalaise d’Urologie: Speaker to be confirmed Kenyan Association of Urological Surgeons: Saeed Samnakay, Kenya AGSSM Lecture: Surgical Management of Sexual Dysfunction: Khaled Dabees, Egypt AFU Lecture: Prostate Cancer Screening–Which Policy in 2010?: Pascal Rischmann, France Panel: The Initiative for Urology Training in Africa: Serigne Gueye, Senegal; Catherine deVries, USAE. O. Olapade-Olaopa, Nigeria
1300-1400Lunch Break
1400-1800Association Marocaine d’Urologie Symposium
1400-1530Part 1: Urinary Diversion and Bladder Replacement
Chairs: Abdennabi Joual, Morocco
Abdellatif Benchekroun, Morocco
Continent Urinary Diversion: Abdellatif Benchekroun, Morocco, Fethi Meziane, Morocco Differential Indication Continent vs. Incontinent Urinary Diversion: Detlef Frohneberg, Germany Bladder replacement: Abdennabi Joual Panel Discussion1530-1600Break
1600-1700Part 2: Urinary Lithiasis
Chairs: Mohamed Marzouk
Driss Touiti
Badreddine Kadiri
Percutaneous Nephrolithotomy: Mohamed Lezrak Flexible Ureteroscopy: Mohamed Tligui Open Surgery: Hamid Fekak Laparoscopic Treatment: Ismail Sarf1700-1800Part 3: Video Session
Chairs: Redouane Rabii
Ahmed Alj
V1 – Percutaneous Treatment of Renal Hydatic CystM. Lezrek, Morocco
V2 - Laparoscopic Ureteroneocystostomy and Vesicopsoas Hitch for the Management of TuberculosisLower Ureteric Stricture
F. Barjani, Morocco
V3 - Appendico-Ureteroplasty for Urethral StrictureS.El Yacoubi, Morocco
V4 – Renal Hydatic Cyst Laparoscopic Surgery Tip and TrucR. Rabii, Morocco
V5 – Laparoscopic Treatment of CystoceleY. Haddane, Morocco
1400-1800Urodynamics Course
Chairs: Marcus Drake, UK
Sherif Mourad, Egypt
Voiding Diaries UDS for SUI and OAB UDS for Male Voiding Dysfunction UDS for Neurogenic Patients Interpretation of Results Writing a Report1500-1800VVF Course
Chairs: Serigne Gueye, Senegal
Mulu Muleta, Ethiopia
Introduction: Serigne Gueye Diagnosis and Evaluation: Sanda Ganda, Niger Classifications: Kalilou Ouattara, Mali Management of Simple VVF: Theobald Hategekimana, Rwanda Management of Complex VVF: Steve Arrowsmith, USA Management of SUI After Fistula Repair: Mulu Muleta, Ethiopia Setting up a Facility for Fistula Treatment: Serigne Gueye1800-1900Opening Ceremonies
1900-2100Exhibit Hall Opening and Welcome Reception
Thursday, october 14
0700-0800Surgical Tips: VVF
Chairs: Serigne Gueye, Senegal
Suzy Elneil, UK
How I Do Transvaginal VVF Repair: Kalilou Ouattara, Mali How I Do Transabdominal VVF Repair: Issa Labou, Senegal How I Manage Circumferential VVF: Steve Arrowsmith, USA0700-0815Sponsored Symposia
Cook Medical
Biodesign: Surgisis Peyronies Repair Graft
Chair: Kenneth W. Angermeier, USA
0700-0710 Introduction: Kenneth W. Angermeier 0710-0730 Surgisis Biodesign - My Failed Patients: Richard A. Santucci, USA 0730-0750 Surgisis Biodesign - My Successful Patients: Gerald H. Jordan, USA 0750-0810 Panel Discussion and Question and Answer: All 0810-0815 Closing Comments: Kenneth W. Angermeier0815-1015Plenary: OAB
Chair: Marcus Drake, UK
Pathophysiology of OAB: Marcus Drake, UK Assessment of OAB/DO: Sender Herschorn, Canada Evidence-based Medical Treatment of OAB: Luc Valiquette, Canada Treating OAB Drug Failure: Ruud Bosch, Netherlands1015-1030Break
1030-1230Plenary: Report of the 1st ICUD-SIU Consultation on VVF
Chairs: Serigne Gueye, Senegal
Zakaria Behlanech, Morocco
Room: Ministres
1030-1050 Epidemiology: Mulu Muleta, Ethiopia 1050-1110 Prevention Strategy: Alice Emasu, Uganda 1110-1130 Unmet Needs: Suzy Elneil, UK 1130-1150 Surgery for Fistula: Dirk De Ridder, Belgium 1150-1210 Complications from Fistula: Sherif Mourad, Egypt 1210-1230 Social Integration: Rahmat Mohammad, Nigeria1230-1345Lunch Break
Sponsored Symposia
Astellas Pharma
OAB: The Grand Round
Chair: Paul Abrams, UK
1230-1235 Introduction: Paul Abrams 1235-1255 Patient Communication: Gamal Ghoniem, USA 1255-1315 Managing the Female Patient: Chris Payne, USA 1315-1335 Managing the Male Patient: Roger Dmochowski, USA 1335-1345 Question and Answer Session: Paul Abrams 1345 Summary and Close1345-1545Plenary: Post-prostatectomy Incontinence
Chairs: Anthony Schaeffer, USA
Ahmed Ameur, Morocco
AUA Lecture: Incontinence–Past, Present, Future: Anthony Schaeffer, USA Technical and Anatomical Features in the Avoidance of Post-Radical Prostatectomy Urinary Incontinence: Vincent Delmas, France
Postoperative Rehabilitation for Continence: Christian Hampel, Germany Mechanics of Incontinence and Diagnostics: Dirk De Ridder, Belgium Case Presentations and Discussion: Faculty1545-1600Break
1600-1800Plenary: Infections
Chairs: Chris Heyns, South Africa
Mouâd Nouri, Morocco
Chronic Genitourinary Infections in Africa and Asia Tuberculosis: Redouane Rabii, Morocco Bilharzia: Kasonde Bowa, Zambia The Role of Circumcision on HIV Prevention: Stephen Watya, Uganda Global Alliance for Elimination of Lymphatic Filariasis: Sunny Doodu Mante, Ghana Surgery of Lower Urinary Tract Bilharzial Complications: Ismail Khalaf, Cairo, Egypt1600-1800Podium Session 1: Post-Prostatectomy
1600-1800Moderated Video Session 1
1600-1800Moderated Poster Sessions 1-3
Moderated Poster Session 1: Male Lower Urinary Tract Symptoms
Moderated Poster Session 2: Strictures/VVF
Moderated Poster Session 3: Basic Science/Chronic Pelvic Pain Syndrome
Friday, october 15
0700-0800Surgical Tips: Post-prostatectomy Incontinence
Chair: Dirk De Ridder, Belgium
Welcome and Introduction: Dirk De Ridder Artificial Sphincter: TBC InVance Male Sling: TBC AdVance Sling: Dirk De Ridder Discussion: All0700-0815Sponsored Symposia
Astellas Pharma
Unravelling the Colour Spectrum of Male LUTS
Chair: Mark Speakman, UK
0700-0710 Introduction: Mark Speakman 0710-0720 Male LUTS: Need for Better Assessment of Storage Symptoms: Tim Schneider, Germany 0720-0745 Improving Nocturia and Sleep: Colouring Your Patient's Day:Emmanuel Chartier-Kastler, France
0745-0810 Male LUTS: Which Direction to go In Case of Persistent Storage Symptoms:David Castro-Diaz, Spain
0810-0815 Closing remarks: Mark Speakman0815-1015Plenary: Male Voiding Dysfunction
Chairs: Joachim Thüroff, Germany
Ismail Sarf, Morocco
EAU Lecture: MLUTS Assessment and Triage: Christopher Chapple, UK Medical Therapy for BPO: International Perspective: Mark Speakman, UK Panel: MIS–An Advance, Cost-Effective?: Andreas Gross, GermanyChristopher Cheng, Singapore, Rainer Kuntz, Germany
1015-1030Break
1030-1230Plenary: Urological Chronic Pelvic Pain Syndromes (UCPPS):
2000-2010, A Decade of Progress
Chair: J. Curtis Nickel, Canada
The Evolution of Definitions, Diagnosis and Nomenclature: Jean-Jacques Wyndaele, Belgium Evidence-based Management of Male UCPPS(Chronic Prostatitis/Chronic Pelvic Pain Syndrome): Michel Pontari, USA
Evidence-based Management of Female UCPPS(Interstitial Cystitis/Bladder Pain Syndrome): Jorgen Nordling, Denmark
Debate: Are Male and Female UCPPS the Same Condition?Pro: Karl Kreder, USA
Con: Anthony Schaeffer, USA
Case-based Debate: When Evidence-based Medicine Fails, What Next?Faculty
What Have We Learned/Where Are We Going? J. Curtis Nickel1230-1345Lunch Break
Sponsored Symposia
GlaxoSmithKline
Effective Management of BPH with Combination Therapy
Chair: Abdennabi Joual, Morocco
1230-1235 Introduction: Abdennabi Joual 1235-1315 Effective Management of BPH with Combination Therapy: Claus Roehrborn, USA 1315-1325 Question and Answer Session: Claus Roehrborn, USA 1325-1330 Summary and Closing Remarks: Abdennabi Joual1230-1345Sponsored Symposium
Pfizer
1230-1235Welcome and Introduction
1235-1250Building on the Detrusitol Legacy
Alan J. Wein, USA
1250-1310Opening the Door to Toviaz
Christopher Chapple, UK,
1310-1330Toviaz 4 mg and 8 mg for Individualized Care
David Staskin, USA
1330-1345Panel Discussion with Q&A
1345-1545Plenary: ICUD Consultation on Urethral Strictures: Committee Presentations
Chairs: Gerald H. Jordan, USA
Christopher Chapple, UK
Chris F. Heyns, South Africa
1345-1357Epidemiology, Anatomy and Nomenclature
Jerilyn Latini, USA
1357-1409Evaluation and Follow-up
Ken Angermeier, USA
1409-1421IU/Dilations/Stents
Jill Buckley, USA
1421-1433Anterior Urethra-Primary Anastomosis
Nick Watkin, UK
1433-1445Anterior Urethra-Lichen Sclerosis
Kurt McCammon, USA
1445-1457Anterior Urethra-Single Stage Substitution
Christopher Chapple, UK
1457-1509PFUDD
Reynaldo Gómez, Chile
1509-1521Vesico-Urethral Stenosis after Treatment for Prostate Cancer
Sender Herschorn, Canada
1521-1533Pediatric Strictures
George Kaplan, USA
1533-1545Discussion
1545-1600Break
1600-1800Podium Session 2: Neuro-urology
1600-1800Moderated Video Session 2
1600-1800Moderated Poster Sessions 4-6
Moderated Poster Session 4: Stress Urinary Incontinence
Moderated Poster Session 5: BPO
Moderated Poster Session 6: Overactive Bladder
Saturday, october 16
0700-0800Surgical Tips: SUI
Chair: Gopal Badlani, USA
Preoperative Counseling in Patients with Mixed Incontinence: Christopher Chapple, UK Use of Bulking Agents: Sender Herschorn, Canada Choice of Material and Procedure Comparison for SUI: Gopal Badlani0800-1000Plenary: Neuro-urology
Chairs: Jean-Jacques Wyndaele, Belgium
Hassan Shaker, Egypt
Urological Assessment and Management of Congenital Neurological Bladder: Catherine deVries, USA Debate: Modern Management of the Neurogenic Bladder Associated with Spinal Cord Injury: Jean-Jacques Wyndaele, Belgium, Helmut Madersbacher, Austria Complications in Neurogenic Bladder: David Castro Díaz, Spain1000-1015Break
1015-1215Plenary: Female SUI
Chairs: Gopal Badlani, USA
Ahmed Ameur, Morocco
Role of Pelvic Floor Muscle Exercises in the Management of SUI: Kari Bo, Norway Role of Urodynamics in the Surgical Management of SUI: Sherif Mourad, Egypt Advances in the Management of SUI: Gopal Badlani, USA Managing the Complications of Synthetic Tapes for SUI: Karl Kreder, USA1215-1230Closing Remarks and Invitation to Berlin 2011
1300-1700Sponsored Symposium
AstraZeneca Morocco
Prostate Cancer Course: Which Treatments Are On Hand in 2010 and Beyond?
Chairs: Claude Abbou, France
Aziz Akira, Morocco
Richard Fourcade, France
Redouane Rabii, Morocco
1300-1310Introduction: Redouane Rabii
Locally Advanced Prostate Cancer
1310-1335 Surgical Management: Claude Abbou 1335-1355 Radiotherapy Management: Hassan Jouhadi, Morocco 1355-1420 Hormone Therapy: Richard Fourcade 1420-1435 Discussion1435-1450Break
Metastatic Prostate Cancer
1450-1510 Hormone Therapy: Richard Fourcade 1510-1530 Castration-Resistant Prostate Cancer: Mounir Bachouchi, Morocco 1530-1555 Acute Obstructive Anuria: Arthur Smith, USA 1555-1615 Bone Metastasis-Related Pain: Rachid Cherkab, Morocco 1615-1645 3 Case Studies: Treatment Problems in Routine Practice: Redouane Rabii, Hassan Jouhadi and Arthur Smith1645-1700Closing Remarks: Chairs
September 27: Please note that all SIU hotels are now SOLD OUT.